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Results: Irradiation with low doses enhanced the motility of 
the cells. Slit2 as well as Robo1 was extremely low expressed 
in the cell line with higher motility (U87). Irradiation reduced 
the expression even more. On the other hand, a stable 
overexpression of Robo1 decreased significantly the migration 
of the cells and suppressed the increase in motility observed 
after irradiation. In contrast, the siRNA mediated knockdown 
of Robo1 increased the migratory potential of the cells. The 
analysis of FAK, a key player in cellular migration, revealed a 
decreased expression in Robo1-overexpressing cells. 
 
Conclusion: Our data indicate a role for Robo1 in the 
migration of malignant GBM cells. The expression of Robo1 
reduced the migration of these cells and was also able to 
impede the increase in motility observed after irradiation 
with photons. 
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Purpose or Objective: Proton minibeam radiotherapy aims to 
minimize normal tissue damage in the entrance channel 
while keeping tumor control through a homogeneous tumor 
dose due to channel widening with increasing track length. 
Side effects of proton minibeam irradiation were examined in 
an in-vivo mouse model to account for immune system, 
vasculature and higher complexity. Here, we report on our 
comparative study of minibeam and broad beam irradiation in 
the ear of Balb/c mice, to prove this hypothesis of reduced 
adverse effects in normal tissue. 
 
Material and Methods: At the ion microprobe SNAKE, 20 MeV 
protons were administered to the right ear of 2-3 months old, 
female Balb/c mice, using an average dose of 60 Gy in a field 
of 7.2 x 7.2 mm2 in the central part of the ear, in two 
irradiation modes, homogeneous and minibeams. The 4 x 4 
minibeams of 180 x 180 µm2 size were set in a distance of 1.8 
mm, resulting in a dose of 6000 Gy in the channels, but with 
negligible dose in between. Inflammatory response, i.e. ear 
swelling and skin reactions were monitored for 90 days 
following irradiation, as well as genetic damage and release 
of inflammatory proteins. 
 
Results: No ear swelling or other skin reaction was detected 
after the minibeam irradiations, while significant ear swelling 
(up to 4-fold), erythema and desquamation (crust formation) 
developed in homogeneously irradiated ears 3-4 weeks after 
irradiation. Loss of hair follicles was only detected in the 
homogeneously irradiated fields after 4-5 weeks. 
 
Conclusion: Our results prove that proton minibeam 
radiotherapy leads to reduced side effects compared to 
conventional broad beam irradiation and could become an 
option in clinical proton and/or heavy ion therapy.  
Supported by the DFG Cluster of Excellence: Munich-Centre 
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Purpose or Objective: Metastasis is an important cause of 
mortality in cancer patients and evidence shows that 
irradiation could actually increase the formation of 
metastasizing cells. An important pathway implicated in the 
process of metastasis is the Hedgehog (Hh) signaling 
pathway. Recent studies demonstrated that activation of this 
pathway can lead to radioresistance. So far, the impact of 
high-LET radiation on the Hh pathway is still unknown. In the 
present study the impact of different radiation qualities (e.g. 
X-rays and carbon ions) on Hh gene expression was 
investigated in prostate cancer cells (PC3) and 
medulloblastoma cells (DAOY). 
 
Material and Methods: In vitro models used for prostate 
cancer and medulloblastoma were PC3 and DAOY, 
respectively. Colony survival assays were performed to 
analyze the effect of radiation on cell survival. The impact of 
radiation on the expression of the different Hh signaling 
pathway components (SHH, PTCH, SMO, GLI1, GLI2, GLI3 and 
SUFU) was investigated by means of RT-qPCR. Experiments 
with X-rays were performed at SCK•CEN (Mol, Belgium) 
whereas carbon ion irradiation (LET = 33.7 KeV/µm) 
experiments were performed at the Grand Accélérateur 
National d’Ions Lourds (GANIL) (Caen, France).  
 
Results: Colony survival assays showed that DAOY cells were 
more radioresistant than PC3 cells (respectively D10=5.3 Gy 
and D10=4.2 Gy). Evaluation of the Hh signaling pathway 
showed that basal gene expression is present in both PC3 and 
DAOY, although very low. However, basal gene expression of 
the Hh components differed between both cell lines. 
Moreover, the more radioresistant cell line DAOY had higher 
expression levels of Gli1 compared to the PC3 cells. 
Preliminary RT-qPCR results show that different radiation 
qualities induce different changes in the expression of the Hh 
signaling components. 
 
Conclusion: In conclusion, radiation exposure can induce 
changes in the Hh pathway. Future experiments will address 
whether modulation of the Hh pathway also affects the radio-
responsiveness of cancer cells. 
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Purpose or Objective: This retrospective study aimed to 
compare and determine the potential dosimetric benefits of 
intensity-modulated radiotherapy (IMRT) treatment plans 
with (FF) and without flattening filter (FFF) as well as to 
explore the dosimetric differences in 6MV FFF and 10MV FFF 
plans for non-small-cell lung carcinoma (NSCLC). 
 
Material and Methods: Ten cases of CT data were selected 
from NSCLC patients. 4 sets of 5-field-IMRT plans were 
computed with FFF beams (X6FFF, X10FFF) and flattened 
beams (X6FF, X10FF) with the prescription of total 60Gy in 30 
fractions. Planning constraints were based on the Radiation 
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Therapy Oncology Group (RTOG) protocol 1306. 
Determination of isocentre, beam arrangement and dose 
constraints were kept constant in each case. All plans were 
computed using Varian Eclipse version 11.0 treatment 
planning system. The plans were then evaluated based on the 
target coverage, homogeneity, conformity, number of 
monitor units (MU) to be delivered and dose-volume 
constraints for various organs at risk (OARs). 
 
Results: All plans exhibited comparable PTV homogeneity (HI 
≤ 7.5) and conformity (CI > 96%) with a steep dose fall-off 
outside the PTVs but at the expense of increased MUs by 
39.4% (p=0.007) and 44.7% (p=0.005) for FFF beams at 6 MV 
and 10 MV respectively. FFF beams offered better dose 
sparing of OARs than flattened beams. Spinal cord+5mm and 
volume of 'whole lung (WL) – Gross tumour volume (GTV)' 
(WL-GTV) that received 20Gy (V20) were reduced by 2% 
(p=0.017) and 2.8% (p=0.016) respectively in X10FFF plans 
when compared with X10FF plans. There was also a 16.4 % 
dose reduction to brachial plexus in X10FFF plans than X6FFF 
plans. 
 
Conclusion: The application of FFF IMRT for NSCLC yielded 
quantitatively comparable dosimetric distribution with better 
sparing of the OARs including ‘spinal cord+5mm’, V20 of ‘WL-
GTV’ and brachial plexus than using FF beams. 
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Purpose or Objective: There are few studies comparing 3-
dimensional conformal radiation therapy (3DCRT) and 
volumetric modulated arc therapy (VMAT) in treatment of 
esophageal cancer. These studies often compare 3DCRT 
unsophisticated, with few treatment beams, which is not 
common in clinical practice.  
Our aim was to compare a modern 3DCRT plan with VMAT 
using dose volume histograms (DVH) and evaluate the 
dosimetric profile.  
 
Material and Methods: We evaluate 7 patients with 
esophageal cancer (4 medium, 2 distal and 1 upper 
neoplasms). All were contoured using PET-CT and treated 
with radio-chemotherapy. Target volumes for primary lesions 
(50-50,4 Gy) and electively treated regions (45 Gy) were 
contoured. 
Every patient had 2 dose-plans, one with 3DCRT (8-10 beams) 
and other with VMAT (2 arcs) techniques. For each technique, 
we evaluate the coverage target, homogeneity index of PTV 
(HI), conformity index (CI), monitor units and DVH metrics of 
lungs, heart and spinal cord. 
 
Results: VMAT plans reduced total lung volume treated above 
20 Gy (V20) and mean lung dose (MLD), but volume treated 
above 5 Gy (V5) were higher than 3DCRT. VMAT improved 
total heart volume treated above 20 Gy and 40 Gy (V20, V40) 
and maximum dose to cord.  
Monitor units (MU) were higher with the 3DCRT. HI and CI are 
better with VMAT technique. Coverage target was very high 
with both schemes. Statistically meaningful differences were 
observed (Table 1). 
 
Conclusion: Our results suggest that VMAT for radical 
treatment of esophageal cancer is useful for decreasing dose 
in organs at risk. It can play a more important role in some 
locations, such as cervical cancer. Nevertheless, VMAT 
increases low-doses in lung and this may contribute increase 
pulmonary complications.  
A complex multibeam technique -3DCRT preserves constraint 
of organs at risk with high conformity and homogeneity of the 
target. 
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Purpose or Objective: The aim was to investigate whether 
the amplitude level achieved during DIBH impacted on the 
mean cardiac dose and V30 reduction in 30 women treated 
for a left sided breast cancer during radiotherapy. 
 
Material and Methods: Patients were dual scanned in free 
breathing and DIBH. Varian Real-time Position Management 
(RPM) was used to record and monitor breathing. Plans were 
virtually simulated with field borders following IMPORT high 
guidelines. Pinnacle treatment planning software was used 
for dosimetric calculation; all plans conformed to ICRU 62. 
Spearman’s Rank correlation and statistical analysis was 
performed using SPSS v22. All patient data was annonymised. 
To improve reliability and assess validity of the researcher, 
10 of the 30 patients were chosen at random, re-outlined and 
re-planned to confirm consistency and intra-rater reliability. 
The heart was also re-contoured for one patient 5 times to 
calculate the error in heart contouring. 
 
Results: All patients achieved decreased cardiac V30 and 
mean cardiac dose reduction using DIBH technique. Moderate 
positive correlation between DIBH amplitude and cardiac V30 
reduction was statistically significant (p=0.007, R=0.48). 
Ratio increase from free breathing to DIBH and cardiac V30 
reduction was also positively correlated and statistically 
significant (p=0.04, R=0.38). Twenty seven percent of 
patients achieved full cardiac V30 reduction and 73% of 
patients achieved over 90% reduction. Ratio of amplitude 
increase from free breathing to DIBH ranged from 4-27 times 
with ratios of at least 15 times free breathing all achieving 
100% cardiac V30 reduction. However 100% cardiac V30 
reduction was observed with amplitude of ratio increase as 
low as 6.25 times free breathing.  
Positive correlation between DIBH amplitude and mean 
cardiac dose reduction was statistically significant (p=0.003, 
R=0.523). Seventy seven percent of patients achieved over 
50% mean cardiac dose reduction with DIBH amplitudes of 
1.04-5.46cm. Correlation of ratio of amplitude increase from 
free breathing to DIBH and mean cardiac dose reduction was 
not statistically significant (p=0.316, R=0.189). 
 
Conclusion: A 100% reduction in cardiac V30 can be achieved 
with a DIBH amplitude increase 15 times free breathing, yet 
full reduction can also be achieved at much lower levels 
(6.25 times free breathing in the current study) suggesting 
patients unable to achieve a large amplitude increase may 
